.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Accenture
Fuji
McKinsey
Federal Trade Commission
Cerilliant
Chinese Patent Office
AstraZeneca
Daiichi Sankyo
Cantor Fitzgerald

Generated: July 22, 2017

DrugPatentWatch Database Preview

PFIZERPEN Drug Profile

« Back to Dashboard

What is the patent landscape for Pfizerpen, and when can generic versions of Pfizerpen launch?

Pfizerpen is a drug marketed by Pfizer and is included in eight NDAs.

The generic ingredient in PFIZERPEN is penicillin g procaine. There are eighty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the penicillin g procaine profile page.

Summary for Tradename: PFIZERPEN

Patents:0
Applicants:1
NDAs:8
Suppliers / Packagers: see list1
Bulk Api Vendors: see list25
Patent Applications: see list900
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PFIZERPEN at DailyMed

Pharmacology for Tradename: PFIZERPEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
PFIZERPEN
penicillin g potassium
INJECTABLE;INJECTION060657-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pfizer
PFIZERPEN-A
ampicillin/ampicillin trihydrate
CAPSULE;ORAL062050-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pfizer
PFIZERPEN G
penicillin g potassium
TABLET;ORAL060075-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pfizer
PFIZERPEN G
penicillin g potassium
TABLET;ORAL060075-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pfizer
PFIZERPEN VK
penicillin v potassium
FOR SOLUTION;ORAL061815-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
McKinsey
QuintilesIMS
Medtronic
Fish and Richardson
Accenture
Moodys
Boehringer Ingelheim
US Army
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot